Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0660
-0.0010 (-1.49%)
Oct 1, 2026, 4:10 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 70.45 million as of October 1, 2026. Its market cap has increased by 61.45% in one year.
Market Cap
70.45M
Enterprise Value
61.63M
Revenue
3.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 70.45M, an increase of 1,130.70%. That is a compound annual growth rate of 9.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 70.45M | -20.24% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 108.01M |
| Recce Pharmaceuticals | 94.79M |
| Alterity Therapeutics | 90.49M |
| LTR Pharma | 85.44M |
| Avecho Biotechnology | 69.55M |
| Entropy Neurodynamics | 64.53M |
| Neurizon Therapeutics | 60.46M |
| Amplia Therapeutics | 59.03M |